127 results
8-K
EX-5.1
KALV
KalVista Pharmaceuticals Inc
16 Feb 24
KalVista Pharmaceuticals Announces Pricing of a $160.1 Million Public Offering of Common Stock and Pre-Funded Warrants
4:32pm
and executed by the Company (the “Opinion Certificate”). We have not undertaken any independent investigation to verify the accuracy of any such information
8-K
EX-1.1
KALV
KalVista Pharmaceuticals Inc
16 Feb 24
KalVista Pharmaceuticals Announces Pricing of a $160.1 Million Public Offering of Common Stock and Pre-Funded Warrants
4:32pm
.
(i) Independent Accountants. Deloitte & Touche LLP and Deloitte LLP, which have certified the financial statements (which term as used … Prospectus and the Prospectus, are (i) independent registered public accounting firms as required by the Securities Act, the Exchange Act
424B5
KALV
KalVista Pharmaceuticals Inc
16 Feb 24
Prospectus supplement for primary offering
4:29pm
and the accompanying prospectus concerning our industry and the markets in which we operate is based on information from various sources, including independent … expressed in the estimates made by the independent parties and by us.
S-14
USE OF PROCEEDS
We estimate that the net proceeds of this offering
424B5
KALV
KalVista Pharmaceuticals Inc
14 Feb 24
Prospectus supplement for primary offering
5:13pm
, including independent industry publications. In presenting this information, we have also made assumptions based on such data and other similar sources … materially from those expressed in the estimates made by the independent parties and by us.
S-14
USE OF PROCEEDS
We estimate that the net proceeds
8-K
EX-99.1
0m5yg4ko9sk w5
13 Feb 24
Regulation FD Disclosure
6:55am
S-8
qzzn3dmosp
9 Jan 24
Registration of securities for employees
4:24pm
S-8
EX-23.1
3t1carf qloig6q
9 Jan 24
Registration of securities for employees
4:24pm
S-8
EX-5.1
9kna9jqd2mmnioj2
9 Jan 24
Registration of securities for employees
4:24pm
8-K
uvna dnc5
28 Sep 23
Amendments to Articles of Incorporation or Bylaws
4:07pm
DEFA14A
8z41ooxa9
14 Aug 23
Additional proxy soliciting materials
4:11pm
S-8
pq1jj957kkxxeq6pmn3
20 Jun 23
Registration of securities for employees
4:13pm
S-8
EX-23.1
3pjvj dnpf1ned
20 Jun 23
Registration of securities for employees
4:13pm
S-8
EX-5.1
ii0x33og3g k2tcaw
20 Jun 23
Registration of securities for employees
4:13pm